Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

This study has been completed.

Study NCT00301821 Information provided by National Cancer Institute (NCI)

First Received on March 9, 2006. Last Updated on January 20, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse

More general conditions related to this trial

Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

epratuzumab
rituximab
cyclophosphamide
doxorubicin hydrochloride
prednisone
vincristine sulfate

Additional drug interventions recognized in this trial

Doxorubicin
Vincristine

Sponsors listed in this trial

North Central Cancer Treatment Group
National Cancer Institute (NCI)

Back to top of Main Content